Trial
NCT00670150
New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
Sponsor Name Pending
Condition
Acute Promyelocytic Leukemia
Intervention
NRX 195183 (retinoid analogue)
Why stopped
sponsor withdrew support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-27